Diabetes Canada is proud to announce the winners of its End Diabetes Awards, an annual competition that aims to improve the ...

For diabetes researchers across Canada, data from patients is a critical tool in determining what projects will truly make a difference for people living with the disease. Understanding how many ...

The once-a-day semaglutide pill is approved for reducing the risk of heart disease and Type 2 diabetes, the company said in a statement Monday.

An AI-powered lifestyle intervention app for prediabetes reduced the risk of diabetes similarly to traditional, human-led programs in adults in a recent study, researchers from Johns Hopkins Medicine ...